These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35605426)

  • 1. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
    Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension.
    Ehikioya E; Okobi OE; Beeko MAE; Abanga R; Abah NNI; Briggs L; Nwimo PN; Beeko PKA; Nwachukwu OB; Okoroafor CC
    Cureus; 2023 Jul; 15(7):e42332. PubMed ID: 37614273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials.
    Sridharan K; Sequeira RP
    Br J Clin Pharmacol; 2018 Sep; 84(9):1906-1916. PubMed ID: 29974489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    S D; Novri DA; Hamidy Y; Savira M
    F1000Res; 2022; 11():1287. PubMed ID: 37273965
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: A randomised controlled trial.
    Adebayo JA; Nwafor JI; Lawani LO; Esike CO; Olaleye AA; Adiele NA
    Niger Postgrad Med J; 2020; 27(4):317-324. PubMed ID: 33154284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Efficacy and Safety of Intravenous Labetalol Versus Hydralazine for Management of Severe Hypertension in Pregnancy.
    Patel P; Koli D; Maitra N; Sheth T; Vaishnav P
    J Obstet Gynaecol India; 2018 Oct; 68(5):376-381. PubMed ID: 30224842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
    Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
    BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
    Wu HZ; Cheng Y; Yu D; Li JB; Jiang YF; Zhu ZN
    Hypertens Pregnancy; 2022 May; 41(2):126-138. PubMed ID: 35361052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
    Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Garden A; Davey DA; Dommisse J
    Clin Exp Hypertens B; 1982; 1(2-3):371-83. PubMed ID: 7139977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
    Hjertberg R; Faxelius G; Belfrage P
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):611-5. PubMed ID: 8259746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Hjertberg R; Faxelius G; Lagercrantz H
    J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.